Align Technology, Inc. (ALGN) EV/EBITDA Ratio: 13.98x
Is Align Technology, Inc.’s EV/EBITDA ratio high or low?
Align Technology, Inc.'s EV/EBITDA ratio of 13.98x is 46% below its 5-year average of 25.86x, near the low end of its 5-year range (10.45x–85.66x).
As of Thursday, June 11, 2026. 0.55% above its 12-month average of 13.90x.
ALGN EV/EBITDA Ratio Chart
ALGN Average EV/EBITDA Ratio Chart
ALGN Current vs Average EV/EBITDA Ratio Chart
ALGN EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
13.98x
EV/EBITDA RATIO AVG TTM
13.90x
EV/EBITDA RATIO AVG 3Y
20.40x
EV/EBITDA RATIO AVG 5Y
25.86x
EV/EBITDA RATIO AVG 10Y
37.29x
EV/EBITDA RATIO AVG 15Y
31.91x
EV/EBITDA RATIO AVG 20Y
57.84x
CURRENT VS TTM AVG
+0.55%
CURRENT VS 3Y AVG
-31.46%
CURRENT VS 5Y AVG
-45.95%
CURRENT VS 10Y AVG
-62.51%
CURRENT VS 15Y AVG
-56.19%
CURRENT VS 20Y AVG
-75.83%
ALGN Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Align Technology, Inc. (ALGN) | $12.27B | 13.98x | 13.90x | 20.40x | 25.86x |
| Baxter International Inc. (BAX) | $10.49B | 24.37x | 20.31x | 19.09x | 19.10x |
| Charles River Laboratories International, Inc. (CRL) | $8.94B | 14.86x | 19.01x | 15.54x | 17.40x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.92B | 254.89x | 59.27x | 93.59x | 48.31x |
| Hologic, Inc. (HOLX) | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 72.70x | 67.01x | 331.87x | 331.87x |
| Moderna, Inc. (MRNA) | $18.71B | N/A | 12.39x | 25.27x | 25.27x |
| BioNTech SE (BNTX) | $22.39B | N/A | 51.40x | 19.63x | 20.05x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 20.23x | 23.55x | 23.87x | 26.49x |
| Waters Corporation (WAT) | $23.21B | 37.79x | 21.59x | 21.24x | 21.45x |
EV/EBITDA vs. its own history
At 14.0, EV/EBITDA is cheaper than usual, sitting higher than 9% of its 20-year history.
20-year low
8.3
median
25.1
20-year high
2661.4
Align Technology, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Align Technology, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The EV/EBITDA ratio for ALGN stock is 13.98x.
- Is Align Technology, Inc.'s EV/EBITDA ratio high or low?
- Align Technology, Inc.'s EV/EBITDA ratio of 13.98x is 46% below its 5-year average of 25.86x, near the low end of its 5-year range (10.45x–85.66x).
- What is the TTM average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The TTM average EV/EBITDA ratio for ALGN stock is 13.90x.
- What is the 3Y average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The 3Y average EV/EBITDA ratio for ALGN stock is 20.40x.
- What is the 5Y average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The 5Y average EV/EBITDA ratio for ALGN stock is 25.86x.
- What is the 10Y average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The 10Y average EV/EBITDA ratio for ALGN stock is 37.29x.
- What is the 15Y average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The 15Y average EV/EBITDA ratio for ALGN stock is 31.91x.
- What is the 20Y average EV/EBITDA ratio for Align Technology, Inc. (ALGN)?
- The 20Y average EV/EBITDA ratio for ALGN stock is 57.84x.
Align Technology, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-11 | 13.98x |
| 2026-06-10 | 13.92x |
| 2026-06-09 | 14.60x |
| 2026-06-08 | 14.06x |
| 2026-06-05 | 13.68x |
| 2026-06-04 | 13.73x |
| 2026-06-03 | 13.14x |
| 2026-06-02 | 13.58x |
| 2026-06-01 | 13.86x |
| 2026-05-29 | 14.32x |
| 2026-05-28 | 14.17x |
| 2026-05-27 | 13.25x |
| 2026-05-26 | 13.31x |
| 2026-05-22 | 13.31x |
| 2026-05-21 | 13.26x |
| 2026-05-20 | 13.29x |
| 2026-05-19 | 12.56x |
| 2026-05-18 | 12.88x |
| 2026-05-15 | 12.75x |
| 2026-05-14 | 13.04x |
| 2026-05-13 | 13.15x |
| 2026-05-12 | 13.50x |
| 2026-05-11 | 13.40x |
| 2026-05-08 | 13.77x |
| 2026-05-07 | 13.74x |
| 2026-05-06 | 14.23x |
| 2026-05-05 | 13.78x |
| 2026-05-04 | 14.06x |
| 2026-05-01 | 14.68x |
| 2026-04-30 | 14.43x |
| 2026-04-29 | 14.64x |
| 2026-04-28 | 14.54x |
| 2026-04-27 | 15.20x |
| 2026-04-24 | 15.63x |
| 2026-04-23 | 15.73x |
| 2026-04-22 | 16.20x |
| 2026-04-21 | 16.13x |
| 2026-04-20 | 15.82x |
| 2026-04-17 | 15.67x |
| 2026-04-16 | 15.23x |
| 2026-04-15 | 15.36x |
| 2026-04-14 | 15.20x |
| 2026-04-13 | 14.84x |
| 2026-04-10 | 14.17x |
| 2026-04-09 | 14.29x |
| 2026-04-08 | 14.50x |
| 2026-04-07 | 13.62x |
| 2026-04-06 | 14.06x |
| 2026-04-02 | 13.95x |
| 2026-04-01 | 14.14x |
| 2026-03-31 | 14.02x |
| 2026-03-30 | 13.56x |
| 2026-03-27 | 13.57x |
| 2026-03-26 | 14.54x |
| 2026-03-25 | 14.80x |
| 2026-03-24 | 14.72x |
| 2026-03-23 | 14.86x |
| 2026-03-20 | 14.18x |
| 2026-03-19 | 14.45x |
| 2026-03-18 | 14.11x |
| 2026-03-17 | 14.44x |
| 2026-03-16 | 13.84x |
| 2026-03-13 | 13.38x |
| 2026-03-12 | 13.62x |
| 2026-03-11 | 14.32x |
| 2026-03-10 | 13.84x |
| 2026-03-09 | 14.34x |
| 2026-03-06 | 14.25x |
| 2026-03-05 | 14.39x |
| 2026-03-04 | 14.97x |
| 2026-03-03 | 15.01x |
| 2026-03-02 | 15.58x |
| 2026-02-27 | 15.68x |
| 2026-02-26 | 17.20x |
| 2026-02-25 | 17.09x |
| 2026-02-24 | 16.84x |
| 2026-02-23 | 16.43x |
| 2026-02-20 | 17.28x |
| 2026-02-19 | 17.22x |
| 2026-02-18 | 17.36x |
| 2026-02-17 | 17.01x |
| 2026-02-13 | 16.96x |
| 2026-02-12 | 16.68x |
| 2026-02-11 | 18.01x |
| 2026-02-10 | 17.89x |
| 2026-02-09 | 17.52x |
| 2026-02-06 | 17.04x |
| 2026-02-05 | 15.88x |
| 2026-02-04 | 14.49x |
| 2026-02-03 | 14.08x |
| 2026-02-02 | 14.71x |
| 2026-01-30 | 14.66x |
| 2026-01-29 | 14.76x |
| 2026-01-28 | 14.84x |
| 2026-01-27 | 15.05x |
| 2026-01-26 | 15.11x |
| 2026-01-23 | 15.21x |
| 2026-01-22 | 15.23x |
| 2026-01-21 | 15.33x |
| 2026-01-20 | 14.90x |
| 2026-01-16 | 15.48x |
| 2026-01-15 | 15.48x |
| 2026-01-14 | 15.26x |
| 2026-01-13 | 15.35x |
| 2026-01-12 | 15.53x |
| 2026-01-09 | 15.61x |
| 2026-01-08 | 15.39x |
| 2026-01-07 | 15.02x |
| 2026-01-06 | 15.11x |
| 2026-01-05 | 14.37x |
| 2026-01-02 | 13.98x |
| 2025-12-31 | 13.99x |
| 2025-12-30 | 14.18x |
| 2025-12-29 | 14.15x |
| 2025-12-26 | 14.20x |
| 2025-12-24 | 14.15x |
| 2025-12-23 | 14.05x |
| 2025-12-22 | 14.29x |
| 2025-12-19 | 14.14x |
| 2025-12-18 | 14.50x |
| 2025-12-17 | 14.42x |
| 2025-12-16 | 14.64x |
| 2025-12-15 | 14.63x |
| 2025-12-12 | 14.89x |
| 2025-12-11 | 14.74x |
| 2025-12-10 | 14.81x |
| 2025-12-09 | 14.27x |
| 2025-12-08 | 14.14x |
| 2025-12-05 | 14.09x |
| 2025-12-04 | 14.06x |
| 2025-12-03 | 13.88x |
| 2025-12-02 | 13.48x |
| 2025-12-01 | 13.07x |
| 2025-11-28 | 13.12x |
| 2025-11-26 | 13.12x |
| 2025-11-25 | 13.15x |
| 2025-11-24 | 12.77x |
| 2025-11-21 | 12.67x |
| 2025-11-20 | 11.72x |
| 2025-11-19 | 11.80x |
| 2025-11-18 | 11.67x |
| 2025-11-17 | 11.70x |
| 2025-11-14 | 12.14x |
| 2025-11-13 | 12.36x |
| 2025-11-12 | 12.58x |
| 2025-11-11 | 12.86x |
| 2025-11-10 | 12.25x |
| 2025-11-07 | 11.92x |
| 2025-11-06 | 11.81x |
| 2025-11-05 | 12.15x |
| 2025-11-04 | 11.43x |
| 2025-11-03 | 11.69x |
| 2025-10-31 | 11.63x |
| 2025-10-30 | 11.68x |
| 2025-10-29 | 11.09x |
| 2025-10-28 | 11.20x |
| 2025-10-27 | 11.43x |
| 2025-10-24 | 11.39x |
| 2025-10-23 | 11.46x |
| 2025-10-22 | 11.42x |
| 2025-10-21 | 11.48x |
| 2025-10-20 | 11.36x |
| 2025-10-17 | 10.95x |
| 2025-10-16 | 10.90x |
| 2025-10-15 | 10.77x |
| 2025-10-14 | 10.89x |
| 2025-10-13 | 10.87x |
| 2025-10-10 | 10.53x |
| 2025-10-09 | 11.08x |
| 2025-10-08 | 11.20x |
| 2025-10-07 | 10.96x |
| 2025-10-06 | 11.05x |
| 2025-10-03 | 11.11x |
| 2025-10-02 | 10.79x |
| 2025-10-01 | 10.69x |
| 2025-09-30 | 10.48x |
| 2025-09-29 | 10.58x |
| 2025-09-26 | 10.56x |
| 2025-09-25 | 10.45x |
| 2025-09-24 | 10.75x |
| 2025-09-23 | 10.82x |
| 2025-09-22 | 11.02x |
| 2025-09-19 | 11.04x |
| 2025-09-18 | 11.15x |
| 2025-09-17 | 10.86x |
| 2025-09-16 | 11.08x |
| 2025-09-15 | 11.01x |
| 2025-09-12 | 11.06x |
| 2025-09-11 | 11.45x |
| 2025-09-10 | 11.18x |
| 2025-09-09 | 11.46x |
| 2025-09-08 | 11.54x |
| 2025-09-05 | 11.75x |
| 2025-09-04 | 11.34x |
| 2025-09-03 | 11.13x |
| 2025-09-02 | 11.57x |
| 2025-08-29 | 12.01x |
| 2025-08-28 | 11.93x |
| 2025-08-27 | 12.01x |
| 2025-08-26 | 11.99x |
| 2025-08-25 | 12.28x |
| 2025-08-22 | 12.70x |
| 2025-08-21 | 11.89x |
| 2025-08-20 | 12.16x |
| 2025-08-19 | 12.17x |
| 2025-08-18 | 12.28x |
| 2025-08-15 | 12.05x |
| 2025-08-14 | 12.09x |
| 2025-08-13 | 12.35x |
| 2025-08-12 | 11.87x |
| 2025-08-11 | 11.35x |
| 2025-08-08 | 11.82x |
| 2025-08-07 | 11.72x |
| 2025-08-06 | 11.54x |
| 2025-08-05 | 11.85x |
| 2025-08-04 | 11.67x |
| 2025-08-01 | 11.56x |
| 2025-07-31 | 10.87x |
| 2025-07-30 | 17.70x |
| 2025-07-29 | 17.90x |
| 2025-07-28 | 18.03x |
| 2025-07-25 | 17.88x |
| 2025-07-24 | 17.57x |
| 2025-07-23 | 17.75x |
| 2025-07-22 | 16.83x |
| 2025-07-21 | 16.37x |
| 2025-07-18 | 16.53x |
| 2025-07-17 | 16.66x |
| 2025-07-16 | 16.48x |
| 2025-07-15 | 16.71x |
| 2025-07-14 | 17.31x |
| 2025-07-11 | 17.58x |
| 2025-07-10 | 17.78x |
| 2025-07-09 | 17.41x |
| 2025-07-08 | 16.96x |
| 2025-07-07 | 16.81x |
| 2025-07-03 | 17.08x |
| 2025-07-02 | 17.09x |
| 2025-07-01 | 16.85x |
| 2025-06-30 | 16.39x |
| 2025-06-27 | 16.32x |
| 2025-06-26 | 16.25x |
| 2025-06-25 | 16.19x |
| 2025-06-24 | 16.14x |
| 2025-06-23 | 15.85x |
| 2025-06-20 | 15.70x |
| 2025-06-18 | 15.54x |
| 2025-06-17 | 15.10x |
| 2025-06-16 | 15.77x |
| 2025-06-13 | 15.34x |
| 2025-06-12 | 15.69x |
| 2025-06-11 | 16.04x |
| 2025-06-10 | 16.28x |
| 2025-06-09 | 15.62x |
| 2025-06-06 | 15.60x |
| 2025-06-05 | 15.56x |
| 2025-06-04 | 15.54x |
| 2025-06-03 | 15.46x |
| 2025-06-02 | 15.40x |
| 2025-05-30 | 15.63x |
Showing the most recent 260 of 4,735 data points. The chart above shows the full history.
Related Metrics
About Align Technology, Inc.
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Joseph Hogan